Where next for the AstraZeneca share price ahead of Q4 earnings
Markets believe AstraZeneca can continue to deliver strong double-digit growth in 2022, but will the pharma giant’s outlook meet expectations this week?
Source: cityindex.co.uk
Stay updated with breaking news from Astrazeneca Q4. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Markets believe AstraZeneca can continue to deliver strong double-digit growth in 2022, but will the pharma giant’s outlook meet expectations this week?
The Anglo-Swedish drugmaker worked with Oxford to develop one of the first COVID-19 vaccines authorised for widespread use. AstraZeneca said it hopes to cut the time needed to produce large amounts of any new vaccine to between six and nine months